Impact of anti-TNF and anti-IL-12/IL-23 antibody therapy on periodontal inflammation and gingival crevicular fluid IL-6 in patients with inflammatory bowel diseases - Top-Institutions - MDSpire

Impact of anti-TNF and anti-IL-12/IL-23 antibody therapy on periodontal inflammation and gingival crevicular fluid IL-6 in patients with inflammatory bowel diseases

  • By

  • Nicole Neurath

  • Andre Jefremow

  • Selina Sitte

  • Hady Haririan

  • Raja Atreya

  • Marco Kesting

  • June 29, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Friedrich-Alexander University Erlangen-Nuremberg
    Friedrich-Alexander University Erlangen-Nuremberg

    Erlangen, Bavaria

    Key Differentiators

    • Gastroenterology

  • #2

    NYU Langone Health
    NYU Langone Health

    New York, New York

    Key Differentiators

    • Gastroenterology

  • #3

    United Arab Emirates University
    United Arab Emirates University

    Al Ain, Abu Dhabi

    Key Differentiators

    • Gastroenterology

  • #4

    University of California San Diego
    University of California San Diego

    La Jolla, California

    Key Differentiators

    • Gastroenterology

  • #5

    Autonomous University of Madrid
    Autonomous University of Madrid

    Madrid, Madrid

    Key Differentiators

    • Gastroenterology

Original Source(s)

Impact of anti-TNF and anti-IL-12/IL-23 antibody therapy on periodontal inflammation and gingival crevicular fluid IL-6 in patients with inflammatory bowel diseases

  • by Nicole Neurath, Andre Jefremow, Selina Sitte, Hady Haririan, Raja Atreya, Marco Kesting

  • June 29, 2026

Related Content

Intestinal subepithelial myofibroblasts in inflammatory bowel disease: fibroblast heterogeneity, fibrosis, and therapeutic targeting

Evidence-based summary of optimal home self-management for elderly ostomy patients

Casein hydrolysate promotes intestinal repair in adult mice with Salmonella enteritis through a lactate-GPR81-Wnt3A axis in intestinal stem cell niche